跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,196 条关于
“PIV3 PreF”
全部
5,196
临床试验
4,955
药物
53
机构
12
资讯
176
11天前
Clover Reports Positive Phase 2 Data for RSV + hMPV ± PIV3 Combination Vaccines in Older Adults
11个月前
Clover Biopharmaceuticals Reports Positive Phase I Data for First-in-Class RSV-hMPV-PIV3 Combination Vaccines
去年
Clover Advances RSV Vaccine Program with FDA Clearance for Revaccination Trial
3年前
Clover Biopharmaceuticals Advances RSV Vaccine SCB-1019 with U.S. IND Clearance for Revaccination Study
2年前
RSV Vaccine Development Surges with New Approvals and Diverse Strategies
11个月前
Clover Biopharmaceuticals Appoints Nicholas Jackson as President of Global R&D to Advance RSV Combination Vaccine Development
去年
Sanofi Acquires Vicebio for $1.15 Billion to Expand Respiratory Vaccine Pipeline with Molecular Clamp Technology
去年
RSV Vaccines Show Weaker Immune Response in Immunocompromised Older Adults
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
上个月
ACOG Releases 2026–27 Respiratory Virus Immunization Guidance, Extending RSV Vaccination Window for Pregnant Individuals
第 1 页,共 18 页
上一页
下一页